Skip to main content
Premium Trial:

Request an Annual Quote

Denator Inks Swiss Distribution Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swiss distribution company Bucher Biotec will sell and service Denator's heat inactivation technology, used in handling biosamples, in Switzerland under an exclusive agreement, Denator said today.

Denator's Stabilizor T1 technology is used to stabilize tissues and fluids from the moment the sample is taken, and to keep enzymes from degrading.

Used for protein and peptide analysis, the technology can enhance the reliability of data interpretation and can reveal proteins and peptides that might otherwise be lost or undetectable due to degradation, Sweden-based Denator said.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.